David Gisselsson

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 91 publications

Genomic Medicine Sweden: Advancing precision medicine at the national level.

Genomic Medicine Sweden: Advancing precision medicine at the national level.

Journal: Journal of internal medicine

Published: July 07, 2026

Future-proofing medicine for a world of volatility, uncertainty, complexity, and ambiguity.

Future-proofing medicine for a world of volatility, uncertainty, complexity, and ambiguity.

Journal: Academic medicine : journal of the Association of American Medical Colleges

Published: February 08, 2026

GSPT1-specific protein degradation is effective in preclinical models of chemoresistant MYCN-amplified neuroblastoma.

GSPT1-specific protein degradation is effective in preclinical models of chemoresistant MYCN-amplified neuroblastoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 11, 2025

Clonal evolution and therapy resistance in the era of precision cancer medicine: evolutionary trajectories in pediatric cancer.

Clonal evolution and therapy resistance in the era of precision cancer medicine: evolutionary trajectories in pediatric cancer.

Journal: Seminars in cancer biology

Published: July 28, 2025

Why the military should be interested in biomedical technology: four domains of innovation that could change fighting power.

Why the military should be interested in biomedical technology: four domains of innovation that could change fighting power.

Journal: Biotechnology advances

Published: April 04, 2025

Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer.

Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer.

Journal: Scientific reports

Published: March 22, 2025

Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression.

Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression.

Journal: Cancer letters

Published: February 25, 2025

Tracing metastatic spread in pediatric solid tumors using copy number and targeted deep sequencing.

Tracing metastatic spread in pediatric solid tumors using copy number and targeted deep sequencing.

Journal: The Journal of pathology

Published: November 21, 2024

Logistics for Rapid Isolation of Viruses From Humans.

Logistics for Rapid Isolation of Viruses From Humans.

Journal: Health security

Published: October 22, 2024

Evolutionary unpredictability in cancer model systems.

Evolutionary unpredictability in cancer model systems.

Journal: Scientific reports

Published: September 23, 2024

Weaponized genomics: potential threats to international and human security.

Weaponized genomics: potential threats to international and human security.

Journal: Nature reviews. Genetics

Published: November 22, 2023

Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors-a nationwide, prospective Swedish study.

Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors-a nationwide, prospective Swedish study.

Journal: The Lancet regional health. Europe

Published: November 20, 2023

Showing 1-12 of 91

Last Updated: 09/26/2026